| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.02. | Medline reports growth in Q4 despite earnings shortcomings | ||
| 25.02. | Abbott offers $20B in notes to finance Exact Sciences acquisition | ||
| 25.02. | Quantum Surgical acquires Neuwave Medical from J&J to form new surgical robotic venture | ||
| 25.02. | LivaNova reports 12% sales growth in Street-beating Q4 | ||
| 25.02. | Globus Medical surpasses market expectations, driven by acquisitions | ||
| 25.02. | Neurent Medical reports positive findings for Neuromark chronic rhinitis device | ||
| 24.02. | CereVasc has 'encouraging' eShunt data | ||
| 24.02. | Stryker launches next-gen syndesmotic fixation device for ankle stabilization | ||
| 24.02. | Recor Medical also secures renal denervation reimbursement in Japan | ||
| 24.02. | Brainomix extends Series C to $25.4M for AI stroke imaging tech | ||
| 24.02. | Medtronic MiniMed Diabetes unit prices IPO at up to $784M | ||
| 24.02. | Haemonetics gets FDA nod for next-gen plasma collection system | ||
| 23.02. | Biotronik wins FDA nod for pacing lead for LBBAP | ||
| 23.02. | Boston Scientific adds Starbucks CFO, Takeda CEO to board of directors | ||
| 23.02. | Masimo founder Joe Kiani becomes SMSbiotech's board chair | ||
| 23.02. | Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software | ||
| 20.02. | Pulse Biosciences CTO outlines his strategy for medtech success | ||
| 20.02. | Science, Neurosoft partner on BCI tech | ||
| 20.02. | Medtronic Diabetes to lay off 81 employees ahead of MiniMed separation | ||
| 20.02. | AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker | ||
| 20.02. | ICU Medical resolves Smiths Medical warning letter, posts mixed Q4 | ||
| 20.02. | Pharoah Neuro raises $20M, names former Medtronic exec as CEO | ||
| 20.02. | Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit | ||
| 20.02. | iRhythm stock gains on Street-beating Q4, upcoming growth drivers | ||
| 19.02. | Tandem stock rises on Q4 beats, new pay-as-you-go model |